Archive for the Immunotherapy Category
Provectus Pharmaceuticals, Inc. (PVCT), which develops cancer drugs similar to Dendreon Corporation (DNDN) or Genta Incorporated (GETA), has been entered into the Cancer Immunotherapy Index created by Mike Havrilla, …
Tags:
Dendreon,
Dndn,
Drugs Similar,
Geta,
Has Been,
Immunotherapy,
Pharmaceuticals,
Provectus Pharmaceuticals,
Pvct,
Which Develops Posted in
Immunotherapy on March 17, 2010 | There are currently
No Comments
Mesothelioma cancer is a form of cancer that has been linked to asbestos exposure and can affect the lungs, abdomen and the heart.
Tags:
Abdomen And,
Affect The,
Affect The Lungs,
Anipulates The Body,
Been Linked,
Beneficially Manipulates,
Fight Disease,
Heart,
Immune System,
The Heart Posted in
Immunotherapy on March 15, 2010 | There are currently
No Comments
Immunotherapy techniques, if proven sufficiently effective in destroying cancer cells, will bring a great change to current cancer treatments and could vastly improve the prognosis of diseases like mesothelioma.
Tags:
A Great Change,
Diseases Like,
Great Change,
Immunotherapy,
Improve The,
Improve The Prognosis,
Prognosis,
Proven Sufficiently,
Sufficiently Effective,
Treatment,
Treatments And,
Will Bring Posted in
Immunotherapy on March 14, 2010 | There are currently
No Comments
Multikine®, is an immunotherapeutic agent being developed as a first-line treatment for cancer , composed of a mixture of cytokines that both kills cancer cells.
The role of this article is to summarize the main side effects caused by different types of conventional cancer treatments and potential natural treatment (including nutrition, remedies and immunotherapy ). …
Tags:
Article,
Different Types,
Including Nutrition,
Main,
Main Side,
Potential Natural,
Remedies And,
Summarize The,
Summarize The Main,
Treatments And Posted in
Immunotherapy on March 12, 2010 | There are currently
No Comments
Multicenter, Open Label, Phase 2 Study of Sipuleucel-T in Men with Metastatic Castrate Resistant Prostate Cancer (CRPC). Autologous dendritic cells loaded.
Transgene of France has signed an exclusive option agreement with Novartis for the development and commercialisation of the targeted immunotherapy product TG4010 for the first-line treatment of non-small cell lung cancer (NSCLC) and …
e) Genetic immunotherapy .
DURHAM, N.C.–(BUSINESS WIRE)–Mar 8, 2010 – Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly … Argos is an immunotherapy company developing new treatments for cancer , infectious and autoimmune diseases, and transplantation rejection. The Company has generated multiple platform technologies and a diverse pipeline of products based on …
Treatment . Surgery – Surgery is an operation that involves removal of cancerous part of the colon. It acts as a primary treatment for colon cancer